TABLE 1.
Level of evidence | Definition |
1a | Systematic review of randomized controlled trials (homogeneity) |
1b | Individual randomized controlled trials (narrow confidence interval) |
1c | When all patients died before the measure was introduced, but some patients now survive on it. |
2a | Systematic review of cohort studies (homogeneity) |
2b | Individual cohort studies (including low-quality randomized controlled trials; e g., follow-up rate < 80%) |
2c | A study of the outcome; an ecological study |
3a | Systematic review of case–control studies (homogeneity) |
3b | Individual case-control study |
4 | Case series (and poor-quality cohort studies and case–control studies) |
5 | Lack of clear and strictly evaluated expert advice, or derived from physiology, laboratory research, or “first principles” |
| |
Level of recommended | Definition |
| |
A | Evidence of consistent level 1 |
B | Consistent level 2 or 3 evidence, or extrapolation based on level 1 evidence. (“extrapolation” means that data are applied to situations with potentially clinically important differences rather than the original research) |
C | Level 4 evidence, or extrapolation based on level 2 or 3 evidence |
D | Level 5 evidence, either inconsistent or inadequate research (any level) |
OCEBM, Oxford University Center for Evidence-Based Medicine.